Profile
Versant Ventures is a leading healthcare investment firm committed to helping exceptional entrepreneurs build the next generation of great companies. The firm’s emphasis is on biotechnology companies that are discovering and developing novel therapeutics. With $2.4 billion under management and offices in the U.S., Canada and Europe, Versant has built a team with deep investment, operating and clinical expertise that enables a hands-on approach to company building. Since the firm’s founding in 1999, more than 70 Versant companies have achieved successful acquisitions or IPOs. For more information, please visit www.versantventures.com.
Industry
Versant Venture Management Funds
| Name | Type |
|
|
|
Size | AUM | Launch date |
|---|---|---|---|---|---|---|---|
|
Versant Venture Capital VIII
|
Venture Capital (VC)
|
Biotechnology
Healthcare Services
Medical Devices
Pharmaceuticals
|
Seed
Series A
|
North America
Europe
|
$5-10 m
|
$560 M
|
April 2021
|
|
Versant Voyageurs II
|
Venture Capital (VC)
|
Biotechnology
Healthcare Services
Medical Devices
Pharmaceuticals
Technology
Energy
HealthTech
|
Seed
Series A
|
North America
Europe
|
$5-10 m
|
$140 M
|
April 2021
|
|
Versant Venture Capital VII
|
Venture Capital (VC)
|
Biotechnology
Healthcare Services
Medical Devices
Pharmaceuticals
Technology
Energy
|
Seed
Series A
|
North America
Europe
|
$5-10 m
|
$600 M
|
December 2018
|
|
Versant Venture Capital VI, L.P.
|
Venture Capital (VC)
|
Biotechnology
Healthcare Services
Medical Devices
Pharmaceuticals
MedTech
Technology
Energy
HealthTech
|
Seed
Series A
|
North America
Europe
|
$5-10 m
|
$400 M
|
January 2017
|
Contacts
Instant access on the web. Plans from $129/month — see pricing.